Researchers have discovered a way to potentially make drugs more effective at treating certain blood cancers. Source: Discovery Could Boost New Therapies for Myeloproliferative Neoplasms | Memorial Sloan Kettering Cancer Center
MPN Information and Research Hub
PV Reporter was founded by David Wallace, a polycythemia vera (PV) patient since 2009 and now in remission for over six years. His diagnosis became a catalyst for learning and advocacy. Today, David is a dedicated patient advocate, author, and founder of MPN Cancer Connection. PV Reporter serves as a resource hub, sharing information, insights and fostering support for the global myeloproliferative neoplasm (MPN) community.